A PURPOSE OF REVIEW: To address the controversy around the use of biomarkers for hepatocellular carcinoma (HCC) surveillance in individuals with cirrhosis or chronic hepatitis B who are at risk for development of liver cancer. B RECENT FINDINGS: Recent studies suggest that surveillance for hepatocellular carcinoma is beneficial, even after adjustment for lead time and other biases. Alpha fetoprotein (AFP) is complementary to ultrasound (US) in surveillance, particularly in obese patients and patients with infiltrative tumors. US and AFP are both associated with harms to patients from false positive over-diagnosis, with US appearing to cause greater harms. Including patient demographic characteristics and additional biomarkers into diagnostic models is beneficial. Recent studies emphasize the advantage of time trends in biomarkers over single cross-sectional measurements. C SUMMARY: AFP and other biomarkers are complementary to US in surveillance for HCC, especially when applied in models including patient variables and incorporating time trends in biomarker levels. With advances in genetic and molecular analysis of tumors, we may be poised at the cusp of a revolution in HCC surveillance.
A PURPOSE OF REVIEW: To address the controversy around the use of biomarkers for hepatocellular carcinoma (HCC) surveillance in individuals with cirrhosis or chronic hepatitis B who are at risk for development of liver cancer. B RECENT FINDINGS: Recent studies suggest that surveillance for hepatocellular carcinoma is beneficial, even after adjustment for lead time and other biases. Alpha fetoprotein (AFP) is complementary to ultrasound (US) in surveillance, particularly in obesepatients and patients with infiltrative tumors. US and AFP are both associated with harms to patients from false positive over-diagnosis, with US appearing to cause greater harms. Including patient demographic characteristics and additional biomarkers into diagnostic models is beneficial. Recent studies emphasize the advantage of time trends in biomarkers over single cross-sectional measurements. C SUMMARY:AFP and other biomarkers are complementary to US in surveillance for HCC, especially when applied in models including patient variables and incorporating time trends in biomarker levels. With advances in genetic and molecular analysis of tumors, we may be poised at the cusp of a revolution in HCC surveillance.
Authors: Hager A Ahmed Mohammed; Ju Dong Yang; Nasra H Giama; Jonggi Choi; Hawa M Ali; Kristin C Mara; William S Harmsen; Russell H Wiesner; Michael D Leise; Terry M Therneau; Lewis R Roberts Journal: Liver Cancer Date: 2016-12-17 Impact factor: 11.740
Authors: K Hayashi; T Kumada; S Nakano; I Takeda; K Sugiyama; S Kiriyama; Y Sone; A Miyata; H Shimizu; S Satomura Journal: Am J Gastroenterol Date: 1999-10 Impact factor: 10.864
Authors: Hashem B El-Serag; Fasiha Kanwal; Jessica A Davila; Jennifer Kramer; Peter Richardson Journal: Gastroenterology Date: 2014-01-23 Impact factor: 22.682
Authors: Sarah Berhane; Hidenori Toyoda; Toshifumi Tada; Takashi Kumada; Chiaki Kagebayashi; Shinji Satomura; Nora Schweitzer; Arndt Vogel; Michael P Manns; Julia Benckert; Thomas Berg; Maria Ebker; Jan Best; Alexander Dechêne; Guido Gerken; Joerg F Schlaak; Arndt Weinmann; Marcus A Wörns; Peter Galle; Winnie Yeo; Frankie Mo; Stephen L Chan; Helen Reeves; Trevor Cox; Philip Johnson Journal: Clin Gastroenterol Hepatol Date: 2016-01-13 Impact factor: 11.382
Authors: Jorge A Marrero; Ziding Feng; Yinghui Wang; Mindie H Nguyen; Alex S Befeler; Lewis R Roberts; K Rajender Reddy; Denise Harnois; Josep M Llovet; Daniel Normolle; Jackie Dalhgren; David Chia; Anna S Lok; Paul D Wagner; Sudhir Srivastava; Myron Schwartz Journal: Gastroenterology Date: 2009-04-09 Impact factor: 22.682
Authors: Hla-Hla Thein; Michael A Campitelli; Latifa T Yeung; Ahmad Zaheen; Eric M Yoshida; Craig C Earle Journal: PLoS One Date: 2015-09-23 Impact factor: 3.240
Authors: Tae-Hyung Kim; Sungmin Woo; Sangwon Han; Chong Hyun Suh; Richard Kinh Gian Do; Jeong Min Lee Journal: Acad Radiol Date: 2020-09-20 Impact factor: 5.482
Authors: Henry L Y Chan; Arndt Vogel; Thomas Berg; Enrico N De Toni; Masatoshi Kudo; Jörg Trojan; Anja Eiblmaier; Hanns-Georg Klein; Johannes Kolja Hegel; Ashish Sharma; Kairat Madin; Vinzent Rolny; Marcus-Rene Lisy; Teerha Piratvisuth Journal: JGH Open Date: 2022-05-07
Authors: Jing Tang; Li-Juan Zhang; Min Kang; Rong Huang; Hui-Ye Shu; Hong Wei; Jie Zou; Yi-Cong Pan; Qian Ling; Yi Shao Journal: Front Genet Date: 2022-09-19 Impact factor: 4.772
Authors: Young-Sun Lee; Eunjung Ko; Eileen L Yoon; Young Kul Jung; Ji Hoon Kim; Yeon Seok Seo; Hyung Joon Yim; Kyun-Hwan Kim; So Young Kwon; Jong Eun Yeon; Soon Ho Um; Kwan Soo Byun Journal: J Clin Med Date: 2020-01-23 Impact factor: 4.241